[
    {
        "id": "page62.text2",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p62.i0>\nExample 52\n</text>\n<mol id=p62.i1>\npage_62.mol_0\n</mol>\n<text id=p62.i2>\n(S)-2-(tert-Butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.101 mmol) in DMF(10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl\nmethanesulfonate (22.02 mg,0.101 mmol).The mixture was stirred for 20 hours at 45 °C,\ncooled and diluted with water. The mixture was extracted with ethyl acetate (30 mL),\nwashed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product\nwhich was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether\n(from 10:1 to 1:1) to afford isopropyl(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate\n(42 mg,0.068 mmol, 67.4% yield) as yellow oil.LCMS (M+H)=618.2; Retention time\n(10 mM NH4HCO3)=2.289 min.\n</text>\n<text id=p62.i6>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate\n(42 mg,0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide\n(8.16 mg,0.204 mmol) and stirred for 20 hours at 100°℃.The mixture was concentrated\nunder vacuo, diluted with HCl(1N,0.5 ml),extracted with ethyl acetate (5 ml) and organic\nlayer was concentrated to give crude product. The crude product was purified by Prep-\nHPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250\nmm,10 um; Mobile Phase A:water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in\n8.0 min, stop at 13.0min; Flow Rate (ml/min)30.00} to give the desired product(S)-2-\n(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid(17.5 mg,0.030 mmol, 44.7%\nyield) as white solid. LCMS (M+H)=576.2; Retention time (10 mM NH4HCO3)=1.468\n</text>\n<text id=p63.i0>\nmin.lHNMR(400 MHz,MeOD)δ8.37(d,J=2.8Hz,1H),8.15(s,1H),7.55(dd,J=8.6,\n2.9Hz,1H),7.45(d,J=9.9 Hz,2H),5.84(s,1H),4.26(t,J=6.6Hz,2H),3.80(s,3H),\n3.22 -2.59(m,9H),2.25(s,3H),1.67-1.27(m,12H),1.21(s,9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 52.Step 1",
                    "iupac_name": "isopropyl(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p62.i2"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.101 mmol) in DMF(10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl\nmethanesulfonate (22.02 mg,0.101 mmol).The mixture was stirred for 20 hours at 45 °C,\ncooled and diluted with water. The mixture was extracted with ethyl acetate (30 mL),\nwashed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product\nwhich was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether\n(from 10:1 to 1:1) to afford isopropyl(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate\n(42 mg,0.068 mmol, 67.4% yield) as yellow oil.LCMS (M+H)=618.2; Retention time\n(10 mM NH4HCO3)=2.289 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 52.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_62.mol_0",
                    "detail_ids": [
                        "p62.i6",
                        "p63.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate\n(42 mg,0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide\n(8.16 mg,0.204 mmol) and stirred for 20 hours at 100°℃.The mixture was concentrated\nunder vacuo, diluted with HCl(1N,0.5 ml),extracted with ethyl acetate (5 ml) and organic\nlayer was concentrated to give crude product. The crude product was purified by Prep-\nHPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250\nmm,10 um; Mobile Phase A:water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in\n8.0 min, stop at 13.0min; Flow Rate (ml/min)30.00} to give the desired product(S)-2-\n(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid(17.5 mg,0.030 mmol, 44.7%\nyield) as white solid. LCMS (M+H)=576.2; Retention time (10 mM NH4HCO3)=1.468\nmin.lHNMR(400 MHz,MeOD)δ8.37(d,J=2.8Hz,1H),8.15(s,1H),7.55(dd,J=8.6,\n2.9Hz,1H),7.45(d,J=9.9 Hz,2H),5.84(s,1H),4.26(t,J=6.6Hz,2H),3.80(s,3H),\n3.22 -2.59(m,9H),2.25(s,3H),1.67-1.27(m,12H),1.21(s,9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page63.text6",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p63.i1>\nExample 53\n</text>\n<mol id=p63.i2>\npage_63.mol_0\n</mol>\n<text id=p63.i3>\n(S)-2-(tert-Butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and bromocyclopropane (21.97 mg, 0.182\nmmol). The mixture was stirred for 20 hours at 45°℃, cooled and diluted with water.The\nmixture was extracted with ethyl acetate (30 mL), washed with brine (20 mL), dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.018 mmol,30.4% yield)\nas yellow oil.LCMS(M+H)=550.3; Retention time (10 mM NH4HCO3)=2.062 min\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-\n6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg,0.055 mmol)\nin methanol (10 mL) and water (2 mL) was added sodium hydroxide (2.183 mg,0.055\nmmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo,\ndiluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was\nconcentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009); Column Xtimate Prep C18 OBD,21.2x250mm, 10\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min,\nstop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-\nbutoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-\n</text>\n<text id=p64.i0>\nbipyridin]-5'-yl)acetic acid (6.2 mg,0.012 mmol,22.38 % yield) as white solid.LCMS (M\n+H)=508.2; Retention time (10 mM NH4HCO3)=1.596 min.lHNMR (400 MHz,\nMeOD)88.36 (d, J= 2.8Hz, 1H), 8.16 (s,1H),7.54(dd, J=8.6, 2.9Hz,1H), 7.44 (d, J=\n8.6Hz, 1H),5.85(s,1H), 4.01(d,J=7.0Hz,2H),3.30-2.66(m,7H), 1.66-1.27(m,\n13H),1.21(s,9H),0.72-0.61(m,2H),0.50-0.37(m,2H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 53.Step 1",
                    "iupac_name": "isopropyl (S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p63.i3"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and bromocyclopropane (21.97 mg, 0.182\nmmol). The mixture was stirred for 20 hours at 45°℃, cooled and diluted with water.The\nmixture was extracted with ethyl acetate (30 mL), washed with brine (20 mL), dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.018 mmol,30.4% yield)\nas yellow oil.LCMS(M+H)=550.3; Retention time (10 mM NH4HCO3)=2.062 min",
                    "refs": null
                },
                {
                    "compound_id": "Example 53.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_63.mol_0",
                    "detail_ids": [
                        "p63.i3",
                        "p64.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-\n6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg,0.055 mmol)\nin methanol (10 mL) and water (2 mL) was added sodium hydroxide (2.183 mg,0.055\nmmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo,\ndiluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was\nconcentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009); Column Xtimate Prep C18 OBD,21.2x250mm, 10\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min,\nstop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-\nbutoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-\nbipyridin]-5'-yl)acetic acid (6.2 mg,0.012 mmol,22.38 % yield) as white solid.LCMS (M\n+H)=508.2; Retention time (10 mM NH4HCO3)=1.596 min.lHNMR (400 MHz,\nMeOD)88.36 (d, J= 2.8Hz, 1H), 8.16 (s,1H),7.54(dd, J=8.6, 2.9Hz,1H), 7.44 (d, J=\n8.6Hz, 1H),5.85(s,1H), 4.01(d,J=7.0Hz,2H),3.30-2.66(m,7H), 1.66-1.27(m,\n13H),1.21(s,9H),0.72-0.61(m,2H),0.50-0.37(m,2H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page64.text8",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p64.i2>\nExample 54\n</text>\n<mol id=p64.i3>\npage_64.mol_0\n</mol>\n<text id=p64.i4>\n(S)-2-(tert-Butoxy)-2-(5-(cyclobutylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (32 mg, 0.065 mmol) in DMF (10\nmL),K2CO3(8.92 mg,0.065 mmol) and bromocyclobutane (8.72 mg, 0.065 mmol) was\nadded. The mixture was stirred for 20 hours at 45 °C,cooled and diluted with water. The\nmixture was extracted with ethyl acetate (30 mL),washed with brine (20 mL),dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1to 1:1) to isopropyl\n(S)-2-(tert-butoxy)-2-(5-(cyclobutylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetate (32 mg,0.014 mmol, 22.19% yield) as yellow oil.LCMS (M\n+H)=564.4; Retention time(10 mM NH4HCO3)=2.326min.\n</text>\n<text id=p64.i8>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(cyclobutylmethoxy)-6'-\nmethyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (32 mg,0.057 mmol) in\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (6.81 mg,0.170 mmol)\nand stirred for 20 hours at 100°C. The mixture was concentrated under vacuo, diluted with\nHCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was concentrated to\ngive crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281\n(PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm, 10 um; Mobile Phase A:\nwater (10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min;\n</text>\n<text id=p65.i0>\nFlow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-butoxy)-2-(5-\n(cyclobutylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic\nacid (7.7 mg, 0.015 mmol, 26.0% yield) as white solid.LCMS (M+H)=522.2; Retention\ntime(10mM NH4HCO3)=1.709min.lHNMR(400 MHz,MeOD)88.36(d,J=2.8Hz,\n1H),8.16(s,1H),7.55(dd,J=8.6,2.9Hz,1H),7.44-7.43(m,1H),5.85(s,1H),4.13(d,J\n=6.6Hz,2H),3.30-2.66(m, 7H),2.27-1.92(m, 6H), 1.66-1.28(m,13H), 1.21(s,9H)\nExample 55\n</text>\n<mol id=p65.i3>\npage_65.mol_0\n</mol>\n<text id=p65.i4>\n(S)-2-(tert-Butoxy)-2-(5-(2-isopropoxyethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol)in DMF(10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(2-bromoethoxy)propane (30.3 mg,\n0.182 mmol). The mixture was stirred for 20 hours at 45°C,cooled and diluted with water.\nThe mixture was extracted with ethyl acetate (30 mL), washed with brine (20 mL), dried\nover Na2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to isopropyl\n(S)-2-(tert-butoxy)-2-(5-(2-isopropoxyethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetate (27 mg, 0.024 mmol,39.4% yield) as yellow oil.LCMS (M+\nH)=582.5; Retention time (10 mM NH4HCO3)=2.021 min.\n</text>\n<text id=p65.i7>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-isopropoxyethoxy)-\n6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (27 mg, 0.046 mmol)\nin methanol (10 mL) and water (2 mL) was added sodium hydroxide (5.57 mg, 0.139\nmmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo,\ndiluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was\nconcentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009);Column Xtimate Prep C18 OBD,21.2x250 mm,10\n</text>\n<text id=p66.i0>\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min,\nstop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product(S)-2-(tert-\nbutoxy)-2-(5-(2-isopropoxyethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-\nbipyridin]-5'-yl)acetic acid (16.1 mg,0.030 mmol, 64.3 % yield) as white solid.LCMS (M\n+H)=540.2; Retention time (10 mM NH4HCO3)=1.594 min.lHNMR (400 MHz,\nMeOD)88.40(d, J=2.7Hz, 2H), 8.17(s,1H), 7.59(dd, J= 8.6,2.9Hz,1H), 7.46 (d, J=\n8.6Hz,1H),5.85(s,1H),4.32-4.24(m,2H),3.87(dd,J=5.3,3.8Hz,2H),3.74 (dd,J=\n12.2,6.1Hz,1H),3.30-2.66(m,7H),1.64-1.30(m,12H),1.23-1.21(m,15H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 54.Step 1",
                    "iupac_name": "isopropyl(S)-2-(tert-butoxy)-2-(5-(cyclobutylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p64.i4"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (32 mg, 0.065 mmol) in DMF (10\nmL),K2CO3(8.92 mg,0.065 mmol) and bromocyclobutane (8.72 mg, 0.065 mmol) was\nadded. The mixture was stirred for 20 hours at 45 °C,cooled and diluted with water. The\nmixture was extracted with ethyl acetate (30 mL),washed with brine (20 mL),dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1to 1:1) to isopropyl\n(S)-2-(tert-butoxy)-2-(5-(cyclobutylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (32 mg,0.014 mmol, 22.19% yield) as yellow oil.LCMS (M\n+H)=564.4; Retention time(10 mM NH4HCO3)=2.326min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 54.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(5-(cyclobutylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_64.mol_0",
                    "detail_ids": [
                        "p64.i8",
                        "p65.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(cyclobutylmethoxy)-6'-\nmethyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (32 mg,0.057 mmol) in\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (6.81 mg,0.170 mmol)\nand stirred for 20 hours at 100°C. The mixture was concentrated under vacuo, diluted with\nHCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was concentrated to\ngive crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281\n(PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm, 10 um; Mobile Phase A:\nwater (10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min;\nFlow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-butoxy)-2-(5-\n(cyclobutylmethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic\nacid (7.7 mg, 0.015 mmol, 26.0% yield) as white solid.LCMS (M+H)=522.2; Retention\ntime(10mM NH4HCO3)=1.709min.lHNMR(400 MHz,MeOD)88.36(d,J=2.8Hz,\n1H),8.16(s,1H),7.55(dd,J=8.6,2.9Hz,1H),7.44-7.43(m,1H),5.85(s,1H),4.13(d,J\n=6.6Hz,2H),3.30-2.66(m, 7H),2.27-1.92(m, 6H), 1.66-1.28(m,13H), 1.21(s,9H)",
                    "refs": null
                },
                {
                    "compound_id": "Example 55.Step 1",
                    "iupac_name": "isopropyl(S)-2-(tert-butoxy)-2-(5-(2-isopropoxyethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p65.i4"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol)in DMF(10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(2-bromoethoxy)propane (30.3 mg,\n0.182 mmol). The mixture was stirred for 20 hours at 45°C,cooled and diluted with water.\nThe mixture was extracted with ethyl acetate (30 mL), washed with brine (20 mL), dried\nover Na2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to isopropyl\n(S)-2-(tert-butoxy)-2-(5-(2-isopropoxyethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (27 mg, 0.024 mmol,39.4% yield) as yellow oil.LCMS (M+\nH)=582.5; Retention time (10 mM NH4HCO3)=2.021 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 55.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(5-(2-isopropoxyethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_65.mol_0",
                    "detail_ids": [
                        "p65.i7",
                        "p66.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-isopropoxyethoxy)-\n6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (27 mg, 0.046 mmol)\nin methanol (10 mL) and water (2 mL) was added sodium hydroxide (5.57 mg, 0.139\nmmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo,\ndiluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was\nconcentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009);Column Xtimate Prep C18 OBD,21.2x250 mm,10\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min,\nstop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product(S)-2-(tert-\nbutoxy)-2-(5-(2-isopropoxyethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-\nbipyridin]-5'-yl)acetic acid (16.1 mg,0.030 mmol, 64.3 % yield) as white solid.LCMS (M\n+H)=540.2; Retention time (10 mM NH4HCO3)=1.594 min.lHNMR (400 MHz,\nMeOD)88.40(d, J=2.7Hz, 2H), 8.17(s,1H), 7.59(dd, J= 8.6,2.9Hz,1H), 7.46 (d, J=\n8.6Hz,1H),5.85(s,1H),4.32-4.24(m,2H),3.87(dd,J=5.3,3.8Hz,2H),3.74 (dd,J=\n12.2,6.1Hz,1H),3.30-2.66(m,7H),1.64-1.30(m,12H),1.23-1.21(m,15H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page66.text12",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p66.i2>\nExample 56\n</text>\n<mol id=p66.i3>\npage_66.mol_0\n</mol>\n<text id=p66.i4>\n(S)-2-(tert-Butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF(10\nmL) was added 2-(tert-butoxy)ethyl methanesulfonate (23.76 mg, 0.121 mmol) and K2CO3\n(25.09 mg,0.182 mmol). The mixture was stirred for 20 hours at 45°℃,cooled and diluted\nwith water.The mixture was extracted with ethyl acetate (30 mL), washed with brine (20\nmL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by\nsilica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to\nafford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.023 mmol, 37.2 %\nyield)as brown oil.LCMS(M+H)=596.3; Retention time(10mM NH4HCO3)=2.794\nmin.\n</text>\n<text id=p66.i6>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-\n6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (41 mg,0.069 mmol)\nin methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.26 mg, 0.206\nmmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo,\n</text>\n<text id=p67.i0>\ndiluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was\nconcentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x 250 mm, 10\num;Mobile Phase A: water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in 8.0 min,\nstop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-\nbutoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-\nbipyridin]-5'-yl)acetic acid (16 mg, 0.029 mmol, 42.0 % yield) as white solid. LCMS (M +\nH)= 554.2; Retention time (10 mM NH4HCO3)= 1.643 min. lHNMR (400 MHz, MeOD)\nδ8.40(d, J=2.8Hz, 1H), 8.17(s,1H),7.59(dd, J=8.6, 2.9Hz, 1H), 7.46(d, J=8.6 Hz,\n1H),5.85 (s, 1H),4.31-4.20(m,2H), 3.89-3.76(m,2H), 3.30-2.66(m, 7H),1.65- 1.49\n(m,8H),1.47-1.31(m,4H),1.27(s,9H),1.21(s,9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 56.Step 1",
                    "iupac_name": "isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p66.i4"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF(10\nmL) was added 2-(tert-butoxy)ethyl methanesulfonate (23.76 mg, 0.121 mmol) and K2CO3\n(25.09 mg,0.182 mmol). The mixture was stirred for 20 hours at 45°℃,cooled and diluted\nwith water.The mixture was extracted with ethyl acetate (30 mL), washed with brine (20\nmL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by\nsilica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to\nafford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.023 mmol, 37.2 %\nyield)as brown oil.LCMS(M+H)=596.3; Retention time(10mM NH4HCO3)=2.794\nmin.",
                    "refs": null
                },
                {
                    "compound_id": "Example 56.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_66.mol_0",
                    "detail_ids": [
                        "p66.i6",
                        "p67.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-\n6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (41 mg,0.069 mmol)\nin methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.26 mg, 0.206\nmmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo,\ndiluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was\nconcentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x 250 mm, 10\num;Mobile Phase A: water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in 8.0 min,\nstop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-\nbutoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-\nbipyridin]-5'-yl)acetic acid (16 mg, 0.029 mmol, 42.0 % yield) as white solid. LCMS (M +\nH)= 554.2; Retention time (10 mM NH4HCO3)= 1.643 min. lHNMR (400 MHz, MeOD)\nδ8.40(d, J=2.8Hz, 1H), 8.17(s,1H),7.59(dd, J=8.6, 2.9Hz, 1H), 7.46(d, J=8.6 Hz,\n1H),5.85 (s, 1H),4.31-4.20(m,2H), 3.89-3.76(m,2H), 3.30-2.66(m, 7H),1.65- 1.49\n(m,8H),1.47-1.31(m,4H),1.27(s,9H),1.21(s,9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page67.text15",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p67.i3>\nExample 57\n</text>\n<mol id=p67.i4>\npage_67.mol_0\n</mol>\n<text id=p67.i5>\n(S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-\n[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol)in DMF(10\nmL) was added 4,4,4-trifluorobutyl methanesulfonate (24.96 mg, 0.121 mmol) and K2CO3\n(25.09 mg,0.182 mmol). The mixture was stirred for 20 hours at 45°℃,cooled and diluted\nwith water.The mixture was extracted with ethyl acetate (30 mL), washed with brine (20\nmL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by\nsilica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to\nafford isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-\ntrifluorobutoxy)-[2,3'-bipyridin]-5'-yl)acetate (42 mg,0.026 mmol, 42.4% yield)as brown\noil. LCMS (M +H)=606.4; Retention time (10 mM NH4HCO3)=2.712 min.\n</text>\n<text id=p67.i8>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-[2,3'-bipyridin]-5'-yl)acetate(42 mg,\n</text>\n<text id=p68.i0>\n0.069 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.32\nmg,0.208 mmol) and stirred for 20 hours at 100 C. The mixture was concentrated under\nvacuo, diluted with HCl (1N, 0.5 ml),extracted with ethyl acetate (5 ml) and organic layer\nwas concentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm, 10\num;Mobile Phase A: water (10 mM NH4HCO3); B:MeCN;Gradient 40-68%B in 8.0 min,\nstop at 13.0 min; Flow Rate (ml/min)30.00} to give the desired product(S)-2-(tert-\nbutoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-[2,3'-\nbipyridin]-5'-yl)acetic acid (17.8 mg, 0.032 mmol, 45.5% yield) as white solid. LCMS (M\n+H)=564.2; Retention time (10 mM NH4HCO3)=1.664 min.lHNMR (400 MHz,\nMeOD)8 8.40(d, J=2.8Hz, 1H), 8.17(s,1H), 7.58(dd, J= 8.6,2.9Hz, 1H), 7.47(d, J=\n8.6Hz,1H), 5.85 (s,1H),4.24(t,J=6.0Hz,2H),3.30-2.66(m,7H),2.50-2.36(m,2H),\n2.16-2.09(m,2H),1.66-1.28(m,12H),1.21(s,9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 57.Step 1",
                    "iupac_name": "isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p67.i5"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol)in DMF(10 mL) was added 4,4,4-trifluorobutyl methanesulfonate (24.96 mg, 0.121 mmol) and K2CO3 (25.09 mg,0.182 mmol). The mixture was stirred for 20 hours at 45°℃,cooled and diluted with water.The mixture was extracted with ethyl acetate (30 mL), washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-[2,3'-bipyridin]-5'-yl)acetate (42 mg,0.026 mmol, 42.4% yield)as brown oil. LCMS (M +H)=606.4; Retention time (10 mM NH4HCO3)=2.712 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 57.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_67.mol_0",
                    "detail_ids": [
                        "p67.i8",
                        "p68.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-[2,3'-bipyridin]-5'-yl)acetate(42 mg,\n0.069 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.32 mg,0.208 mmol) and stirred for 20 hours at 100 C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml),extracted with ethyl acetate (5 ml) and organic layer was concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm, 10 um;Mobile Phase A: water (10 mM NH4HCO3); B:MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min)30.00} to give the desired product(S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(4,4,4-trifluorobutoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (17.8 mg, 0.032 mmol, 45.5% yield) as white solid. LCMS (M +H)=564.2; Retention time (10 mM NH4HCO3)=1.664 min.lHNMR (400 MHz, MeOD)8 8.40(d, J=2.8Hz, 1H), 8.17(s,1H), 7.58(dd, J= 8.6,2.9Hz, 1H), 7.47(d, J= 8.6Hz,1H), 5.85 (s,1H),4.24(t,J=6.0Hz,2H),3.30-2.66(m,7H),2.50-2.36(m,2H), 2.16-2.09(m,2H),1.66-1.28(m,12H),1.21(s,9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page68.text18",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p68.i3>\nExample 58\n</text>\n<mol id=p68.i4>\npage_68.mol_0\n</mol>\n<text id=p68.i5>\n(S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-\nyl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF(10\nmL) was added K2CO3 (25.09 mg, 0.182 mmol) and (tetrahydro-2H-pyran-4-yl)methyl\nmethanesulfonate (23.51 mg,0.121 mmol).The mixture was stirred for 20 hours at 45C,\ncooled and diluted with water. The mixture was extracted with ethyl acetate (30mL),\nwashed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product\nwhich was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether\n(from 10:1 to 1:1) to afford isopropyl(S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-\n</text>\n<text id=p69.i0>\nyl)acetate (32 mg, 0.015 mmol,24.05 % yield) as yellow oil.LCMS(M+H)=594.2;\nRetention time (10 mM NH4HCO3)=2.611 min.\n</text>\n<text id=p69.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-\nyl)acetate (32 mg, 0.054 mmol)in methanol (10 mL) and water (2 mL) was added sodium\nhydroxide (6.47 mg, 0.162 mmol) and stirred for 20 hours at 100 °C.The mixture was\nconcentrated under vacuo, diluted with HCl (1N,0.5 ml),extracted with ethyl acetate (5\nml) and organic layer was concentrated to give crude product. The crude product was\npurified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18\nOBD,21.2x250 mm,10 um;Mobile Phase A:water (10 mM NH4HCO3);B: MeCN;\nGradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the\ndesired product (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-\n((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (6.3mg, 0.011\nmmol, 21.19% yield)as white solid.LCMS(M+H)=552.2; Retention time(10 mM\nNH4HCO3)=1.522 min.lHNMR (400 MHz,MeOD)δ8.37(d,J=2.8 Hz, 1H), 8.15 (s,\n1H),7.57(dd,J=8.6, 2.9Hz,1H), 7.46(d,J=8.6Hz,1H),5.85(s,1H),4.04-4.00(m,\n4H),3.51 (t,J=11.0Hz,2H),3.30-2.66(m,7H),2.17-2.16 (m,1H),1.83(d,J=12.4Hz,2H),\n1.67-1.28(m,14H),1.21(s,9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 58.Step 1",
                    "iupac_name": "isopropyl(S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p68.i5",
                        "p69.i0"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF(10 mL) was added K2CO3 (25.09 mg, 0.182 mmol) and (tetrahydro-2H-pyran-4-yl)methyl methanesulfonate (23.51 mg,0.121 mmol).The mixture was stirred for 20 hours at 45C, cooled and diluted with water. The mixture was extracted with ethyl acetate (30mL), washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl(S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate (32 mg, 0.015 mmol,24.05 % yield) as yellow oil.LCMS(M+H)=594.2; Retention time (10 mM NH4HCO3)=2.611 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 58.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_68.mol_0",
                    "detail_ids": [
                        "p69.i1"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate (32 mg, 0.054 mmol)in methanol (10 mL) and water (2 mL) was added sodium hydroxide (6.47 mg, 0.162 mmol) and stirred for 20 hours at 100 °C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml),extracted with ethyl acetate (5 ml) and organic layer was concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2x250 mm,10 um;Mobile Phase A:water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (6.3mg, 0.011 mmol, 21.19% yield)as white solid.LCMS(M+H)=552.2; Retention time(10 mM NH4HCO3)=1.522 min.lHNMR (400 MHz,MeOD)δ8.37(d,J=2.8 Hz, 1H), 8.15 (s, 1H),7.57(dd,J=8.6, 2.9Hz,1H), 7.46(d,J=8.6Hz,1H),5.85(s,1H),4.04-4.00(m, 4H),3.51 (t,J=11.0Hz,2H),3.30-2.66(m,7H),2.17-2.16 (m,1H),1.83(d,J=12.4Hz,2H), 1.67-1.28(m,14H),1.21(s,9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page69.text7",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p69.i5>\nExample 59\n</text>\n<mol id=p69.i6>\npage_69.mol_0\n</mol>\n<text id=p69.i7>\n(2S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydrofuran-3-\nyl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.062\nmmol)in DMF (10 mL) was added K2CO3 (25.7 mg, 0.186 mmol) and (tetrahydrofuran-3-\nyl)methyl methanesulfonate (22.36 mg,0.124 mmol). The mixture was stirred for 20 hours\nat45°C,cooled and diluted with water. The mixture was extracted with ethyl acetate (30\n</text>\n<text id=p70.i0>\nmL), washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude\nproduct which was purified by silica gel chromatography eluting with ethyl\nacetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(4'-(4-\nethyl-4-methylpiperidin-1-yl)-6'-methyl-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-\nbipyridin]-5'-yl)acetate (35 mg,0.019 mmol, 31.0% yield) as a yellow oil.LCMS (M+H)\n=568.2; Retention time (10 mM NH4HCO3)=2.451 min.\n</text>\n<text id=p70.i2>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate\n(31 mg, 0.053 mmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide\n(6.42 mg,0.160 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated\nunder vacuo,diluted with HCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and organic\nlayer was concentrated to give crude product._The crude product was purified by Prep-\nHPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250\nmm, 10 um;Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in\n8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product(2S)-2-\n(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydrofuran-3-\nyl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (11.8 mg, 0.022 mmol, 41.0% yield) as\nwhite solid. LCMS (M+H)=538.2; Retention time (10 mM NH4HCO3)=1.487 min\nlHNMR (400 MHz,MeOD)δ8.38 (d,J=2.8Hz,1H),8.15(s,1H),7.58(dd,J=8.6,2.9\nHz,1H),7.46(d,J=8.6Hz,1H),5.85(s,2H),4.23-4.05(m,2H),3.95(dt,J=14.5,7.4\nHz,2H),3.84-3.71(m,2H),3.30-2.66(m,7H),2.26-2.13(m,1H),1.88-1.80(m,1H),\n1.68-1.28(m,13H),1.21(s,9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 59.Step 1",
                    "iupac_name": "isopropyl (2S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p69.i7",
                        "p70.i0"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.062\nmmol)in DMF (10 mL) was added K2CO3 (25.7 mg, 0.186 mmol) and (tetrahydrofuran-3-\nyl)methyl methanesulfonate (22.36 mg,0.124 mmol). The mixture was stirred for 20 hours\nat45°C,cooled and diluted with water. The mixture was extracted with ethyl acetate (30\nmL), washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude\nproduct which was purified by silica gel chromatography eluting with ethyl\nacetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(4'-(4-\nethyl-4-methylpiperidin-1-yl)-6'-methyl-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-\nbipyridin]-5'-yl)acetate (35 mg,0.019 mmol, 31.0% yield) as a yellow oil.LCMS (M+H)\n=568.2; Retention time (10 mM NH4HCO3)=2.451 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 59.Step 2",
                    "iupac_name": "(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_69.mol_0",
                    "detail_ids": [
                        "p70.i2"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate\n(31 mg, 0.053 mmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide\n(6.42 mg,0.160 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated\nunder vacuo,diluted with HCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and organic\nlayer was concentrated to give crude product._The crude product was purified by Prep-\nHPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250\nmm, 10 um;Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in\n8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product(2S)-2-\n(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-((tetrahydrofuran-3-\nyl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (11.8 mg, 0.022 mmol, 41.0% yield) as\nwhite solid. LCMS (M+H)=538.2; Retention time (10 mM NH4HCO3)=1.487 min\nlHNMR (400 MHz,MeOD)δ8.38 (d,J=2.8Hz,1H),8.15(s,1H),7.58(dd,J=8.6,2.9\nHz,1H),7.46(d,J=8.6Hz,1H),5.85(s,2H),4.23-4.05(m,2H),3.95(dt,J=14.5,7.4\nHz,2H),3.84-3.71(m,2H),3.30-2.66(m,7H),2.26-2.13(m,1H),1.88-1.80(m,1H),\n1.68-1.28(m,13H),1.21(s,9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page70.text28",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p70.i6>\nExample 60\n</text>\n<mol id=p70.i7>\npage_70.mol_0\n</mol>\n<text id=p70.i8>\n(S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-\n4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\n</text>\n<text id=p71.i0>\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (45 mg, 0.091 mmol) in DMF (10\nmL) was added K<sub>2</sub>CO<sub>3</sub> (37.6 mg, 0.272 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl\nmethanesulfonate (28.4 mg, 0.136 mmol). The mixture was stirred for 20 hours at 45 °C,\ncooled and diluted with water. The mixture was extracted with ethyl acetate (30 mL),\nwashed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product\nwhich was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether\n(from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-\nyl)acetate (52 mg, 0.018 mmol, 20.09 % yield) as yellow oil. LCMS (M + H) = 608.5;\nRetention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.338 min.\n</text>\n<text id=p71.i3>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-\nyl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium\nhydroxide (10.27 mg, 0.257 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5\nml) and organic layer was concentrated to give crude product. The crude product was\npurified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18\nOBD, 21.2 x 250 mm, 10 μm; Mobile Phase A: water (10 mM NH<sub>4</sub>HCO<sub>3</sub>); B: MeCN;\nGradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the\ndesired product (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(2-\n(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (17.0 mg, 0.028 mmol,\n32.5 % yield) as white solid. LCMS (M + H) = 566.1; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>)\n= 1.562 min. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.37 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56\n(dd, J = 8.6, 2.9 Hz, 1H), 7.46 (d, J = 8.6 Hz, 1H), 5.86 (s, 1H), 4.23 (t, J = 6.2 Hz, 2H),\n3.97 (dd, J = 11.0, 3.4 Hz, 2H), 3.47 (td, J = 11.9, 2.1 Hz, 2H), 3.30 - 2.66 (m, 7H), 1.93 -\n1.29 (m, 19H), 1.21 (s, 9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 60.Step 1",
                    "iupac_name": "isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p71.i0"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (45 mg, 0.091 mmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (37.6 mg, 0.272 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl methanesulfonate (28.4 mg, 0.136 mmol). The mixture was stirred for 20 hours at 45 °C, cooled and diluted with water. The mixture was extracted with ethyl acetate (30 mL), washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.018 mmol, 20.09 % yield) as yellow oil. LCMS (M + H) = 608.5; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.338 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 60.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_70.mol_0",
                    "detail_ids": [
                        "p71.i3"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (10.27 mg, 0.257 mmol) and stirred for 20 hours at 100 °C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10 μm; Mobile Phase A: water (10 mM NH<sub>4</sub>HCO<sub>3</sub>); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-butoxy)-2-(6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (17.0 mg, 0.028 mmol, 32.5 % yield) as white solid. LCMS (M + H) = 566.1; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.562 min. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.37 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.46 (d, J = 8.6 Hz, 1H), 5.86 (s, 1H), 4.23 (t, J = 6.2 Hz, 2H), 3.97 (dd, J = 11.0, 3.4 Hz, 2H), 3.47 (td, J = 11.9, 2.1 Hz, 2H), 3.30 - 2.66 (m, 7H), 1.93 - 1.29 (m, 19H), 1.21 (s, 9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page71.text9",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p71.i7>\nExample 61\n</text>\n<mol id=p72.i0>\npage_72.mol_0\n</mol>\n<text id=p72.i1>\n(S)-2-(tert-Butoxy)-2-(5-(2-(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-\nyl)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF(10\nmL) was added K2CO3 (16.73 mg, 0.121 mmol) and 2-(cyclopentyloxy)ethyl\nmethanesulfonate (18.91 mg,0.091 mmol).The mixture was stirred for 20 hours at 45°C,\ncooled and diluted with water. The mixture was extracted with ethyl acetate (30 mL),\nwashed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude product\nwhich was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether\n(from 10:1 to 1:1) to afford isopropyl isopropyl (S)-2-(tert-butoxy)-2-(5-(2-\n(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-\nyl)acetate (28 mg, 0.042 mmol, 69.8 % yield) as yellow oil.LCMS (M+H)=608.4;\nRetention time (10 mM NH4HCO3)=2.400 min.\n</text>\n<text id=p72.i5>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-\n(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-\nyl)acetate (28 mg, 0.046 mmol) in methanol (10 mL) and water (2 mL) was added sodium\nhydroxide (5.53 mg, 0.138 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N,0.5 ml),extracted with ethyl acetate (5\nml) and organic layer was concentrated to give crude product. The crude product was\npurified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18\nOBD, 21.2x 250 mm, 10 um;Mobile Phase A: water (10 mM NH4HCO3); B:MeCN;\nGradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the\ndesired product(S)-2-(tert-butoxy)-2-(5-(2-(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-\nazaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (8.4mg,0.015 mmol,32.2 %\nyield) as white solid. LCMS (M+H)=566.1; Retention time (10 mM NH4HCO3)=1.676\nmin. lHNMR (400 MHz, MeOD)δ8.40(d,J=2.7Hz, 1H), 8.16(s, 1H), 7.59(dd, J=8.6,\n</text>\n<text id=p73.i0>\n2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.85(s,1H),4.32-4.24(m,2H),4.10-4.01(m,1H),\n3.87-3.80(m,2H),3.30-2.66(m,7H),1.85-1.28(m,20H),1.21(s,9H)\nExample 62\n</text>\n<mol id=p73.i2>\npage_73.mol_0\n</mol>\n<text id=p73.i3>\n(S)-2-(tert-Butoxy)-2-(5-(2,2-difluorobutoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate(30 mg, 0.061 mmol)in DMF(10\nmL) was added K2CO3 (25.09 mg, 0.182 mmol) and 1-bromobutan-2-one (18.28 mg, 0.121\nmmol). The mixture was stirred for 20 hours at 45°C, cooled and diluted with water.The\nmixture was extracted with ethyl acetate (30 mL),washed with brine (20 mL),dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-5-(2-oxobutoxy)-4'-(8-azaspiro[4.5]decan-8-yl)-\n[2,3'-bipyridin]-5'-yl)acetate (16 mg, 0.028 mmol, 46.7 % yield) as yellow oil. LCMS (M +\nH)=566.5; Retention time (0.01%TFA)=2.202 min.\n</text>\n<text id=p73.i6>\nStep 2: A mixture of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-5-(2-oxobutoxy)-\n4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (16 mg, 0.028 mmol) and\nDAST(5 mL) was stirred for 20 hours at 20°C.The mixture was diluted with water and\nethyl acetate (30 mL),organic layer separated, washed with brine (20 mL), dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(5-(2,2-difluorobutoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-\n8-yl)-[2,3'-bipyridin]-5'-yl)acetate (9 mg, 0.015 mmol, 54.1% yield) as yellow oil.LCMS\n(M+H)=587.3;Retention time (0.01%TFA)=2.218 min\nStep 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2,2-difluorobutoxy)-6'-\nmethyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate(40mg, 0.068 mmol) in\n</text>\n<text id=p74.i0>\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (8.17 mg, 0.204 mmol)\nand stirred for 20 hours at 100 ℃. The mixture was concentrated under vacuo, diluted with\nHCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was concentrated to\ngive crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281\n(PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase A:\nwater (10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min;\nFlow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-butoxy)-2-(5-(2,2-\ndifluorobutoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\n(16.7 mg, 0.030 mmol,43.9% yield) as white solid.LCMS (M+H)=546.2; Retention\ntime (10 mM NH4HCO3)=1.662 min. lHNMR (400 MHz, MeOD) 8δ8.45 (d,J=2.8 Hz,\n1H),8.17(s,1H),7.65(dd,J=8.6,3.0Hz,1H),7.50(d,J=8.6Hz,1H),5.86(s,1H), 4.42\n(t,J=12.0Hz,2H),3.30-2.66(m,7H),2.14-2.13(m,2H),1.70-1.29(m,12H),1.21(s,\n9H), 1.12-1.11(m,3H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 61.Step 1",
                    "iupac_name": "isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p72.i1"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (30 mg, 0.061 mmol) in DMF(10 mL) was added K2CO3 (16.73 mg, 0.121 mmol) and 2-(cyclopentyloxy)ethyl methanesulfonate (18.91 mg,0.091 mmol).The mixture was stirred for 20 hours at 45°C, cooled and diluted with water. The mixture was extracted with ethyl acetate (30 mL), washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (28 mg, 0.042 mmol, 69.8 % yield) as yellow oil.LCMS (M+H)=608.4; Retention time (10 mM NH4HCO3)=2.400 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 61.Step 2",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(5-(2-(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_72.mol_0",
                    "detail_ids": [
                        "p72.i5",
                        "p73.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (28 mg, 0.046 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (5.53 mg, 0.138 mmol) and stirred for 20 hours at 100 °C. The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml),extracted with ethyl acetate (5 ml) and organic layer was concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x 250 mm, 10 um;Mobile Phase A: water (10 mM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product(S)-2-(tert-butoxy)-2-(5-(2-(cyclopentyloxy)ethoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (8.4mg,0.015 mmol,32.2 % yield) as white solid. LCMS (M+H)=566.1; Retention time (10 mM NH4HCO3)=1.676 min. lHNMR (400 MHz, MeOD)δ8.40(d,J=2.7Hz, 1H), 8.16(s, 1H), 7.59(dd, J=8.6, 2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.85(s,1H),4.32-4.24(m,2H),4.10-4.01(m,1H), 3.87-3.80(m,2H),3.30-2.66(m,7H),1.85-1.28(m,20H),1.21(s,9H)",
                    "refs": null
                },
                {
                    "compound_id": "Example 62.Step 1",
                    "iupac_name": "isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-5-(2-oxobutoxy)-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p73.i3"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate(30 mg, 0.061 mmol)in DMF(10 mL) was added K2CO3 (25.09 mg, 0.182 mmol) and 1-bromobutan-2-one (18.28 mg, 0.121 mmol). The mixture was stirred for 20 hours at 45°C, cooled and diluted with water.The mixture was extracted with ethyl acetate (30 mL),washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-5-(2-oxobutoxy)-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (16 mg, 0.028 mmol, 46.7 % yield) as yellow oil. LCMS (M + H)=566.5; Retention time (0.01%TFA)=2.202 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 62.Step 2",
                    "iupac_name": "isopropyl (S)-2-(tert-butoxy)-2-(5-(2,2-difluorobutoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p73.i6"
                    ],
                    "detail": "Step 2: A mixture of isopropyl (S)-2-(tert-butoxy)-2-(6'-methyl-5-(2-oxobutoxy)-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (16 mg, 0.028 mmol) and DAST(5 mL) was stirred for 20 hours at 20°C.The mixture was diluted with water and ethyl acetate (30 mL),organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2,2-difluorobutoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate (9 mg, 0.015 mmol, 54.1% yield) as yellow oil.LCMS (M+H)=587.3;Retention time (0.01%TFA)=2.218 min",
                    "refs": null
                },
                {
                    "compound_id": "Example 62.Step 3",
                    "iupac_name": "(S)-2-(tert-butoxy)-2-(5-(2,2-difluorobutoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_73.mol_0",
                    "detail_ids": [
                        "p73.i6",
                        "p74.i0"
                    ],
                    "detail": "Step 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2,2-difluorobutoxy)-6'-\nmethyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetate(40mg, 0.068 mmol) in\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (8.17 mg, 0.204 mmol) and stirred for 20 hours at 100 ℃. The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and organic layer was concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase A: water (10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give the desired product (S)-2-(tert-butoxy)-2-(5-(2,2-difluorobutoxy)-6'-methyl-4'-(8-azaspiro[4.5]decan-8-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (16.7 mg, 0.030 mmol,43.9% yield) as white solid.LCMS (M+H)=546.2; Retention time (10 mM NH4HCO3)=1.662 min. lHNMR (400 MHz, MeOD) 8δ8.45 (d,J=2.8 Hz, 1H),8.17(s,1H),7.65(dd,J=8.6,3.0Hz,1H),7.50(d,J=8.6Hz,1H),5.86(s,1H), 4.42 (t,J=12.0Hz,2H),3.30-2.66(m,7H),2.14-2.13(m,2H),1.70-1.29(m,12H),1.21(s, 9H), 1.12-1.11(m,3H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
        {
        "id": "page79.text2",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p79.i0>\nExample 69\n</text>\n<mol id=p79.i1>\npage_79.mol_0\n</mol>\n<text id=p79.i2>\n(2S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydrofuran-\n3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and (tetrahydrofuran-3-yl)methyl\nmethanesulfonate (36.4 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃,\ndiluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate(53 mg,0.086 mmol,86%\nyield) as yellow oil. LCMS (M+H)=580.2; Retention time (10 mM NH4HCO3)=2.474\nmin.\n</text>\n<text id=p79.i6>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-\nyl)acetate (53 mg, 0.091 mmol) in methanol (10 mL) and water(2 mL) was added sodium\nhydroxide (10.97 mg, 0.274 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml). Organic\nlayer separated and concentrated to give crude product which was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009); Column Xtimate Prep C18 OBD,21.2x250mm,10\num;Mobile Phase A: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0\nmin,stop at 13.0 min; Flow Rate(ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-\nbipyridin]-5'-yl)acetic acid (27.3 mg, 0.050 mmol, 54.2% yield) as white solid.LCMS (M\n+H)= 538.2; Retention time (10 mM NH4HCO3) = 1.500 min. lHNMR (400 MHz,\nMeOD)δ8.43-8.35(m,1H),8.15 (d,J=10.1Hz,1H),7.59(dt, J=8.6, 2.8 Hz,1H),\n</text>\n<text id=p80.i0>\n7.52-7.41(m,1H),5.82(s,1H),4.12(ddd,J=19.9,13.1,7.8Hz,2H),3.94(qd,J=7.4,\n2.2 Hz,2H),3.86-3.71(m,2H),3.28-2.57(m,8H),2.26-1.26(m,14H),1.20(s,9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 69.Step 1",
                    "iupac_name": "isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p79.i2"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and (tetrahydrofuran-3-yl)methyl\nmethanesulfonate (36.4 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃,\ndiluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate(53 mg,0.086 mmol,86%\nyield) as yellow oil. LCMS (M+H)=580.2; Retention time (10 mM NH4HCO3)=2.474\nmin.",
                    "refs": null
                },
                {
                    "compound_id": "Example 69.Step 2",
                    "iupac_name": "(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_79.mol_0",
                    "detail_ids": [
                        "p79.i6",
                        "p80.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-bipyridin]-5'-\nyl)acetate (53 mg, 0.091 mmol) in methanol (10 mL) and water(2 mL) was added sodium\nhydroxide (10.97 mg, 0.274 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml). Organic\nlayer separated and concentrated to give crude product which was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009); Column Xtimate Prep C18 OBD,21.2x250mm,10\num;Mobile Phase A: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0\nmin,stop at 13.0 min; Flow Rate(ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydrofuran-3-yl)methoxy)-[2,3'-\nbipyridin]-5'-yl)acetic acid (27.3 mg, 0.050 mmol, 54.2% yield) as white solid.LCMS (M\n+H)= 538.2; Retention time (10 mM NH4HCO3) = 1.500 min. lHNMR (400 MHz,\nMeOD)δ8.43-8.35(m,1H),8.15 (d,J=10.1Hz,1H),7.59(dt, J=8.6, 2.8 Hz,1H),\n7.52-7.41(m,1H),5.82(s,1H),4.12(ddd,J=19.9,13.1,7.8Hz,2H),3.94(qd,J=7.4,\n2.2 Hz,2H),3.86-3.71(m,2H),3.28-2.57(m,8H),2.26-1.26(m,14H),1.20(s,9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page80.text4",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p80.i1>\nExample 70\n</text>\n<mol id=p80.i2>\npage_80.mol_0\n</mol>\n<text id=p80.i3>\n(2S)-2-(tert-Butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(octahydroisoquinolin-\n2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.101 mmol)in (10\nmL),was added 2-(tert-butoxy)ethyl methanesulfonate (39.6 mg,0.202 mmol) and K2CO3\n(41.8 mg,0.303 mmol). The mixture was stirred for 20 hours at 45°℃,diluted with water\nand ethyl acetate (30 mL),organic layer separated, washed with brine (20 mL), dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ether acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (2S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (51 mg, 0.081 mmol, 80 %\nyield)as brown oil. LCMS (M+H)=596.3; Retention time (10 mM NH4HCO3)=2.786\nmin.\n</text>\n<text id=p80.i6>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(2-(tert-\nbutoxy)ethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate\n(51 mg,0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide\n(10.27 mg, 0.257 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated\nunder vacuo, diluted with HCl(1N,0.5 ml) and ethyl acetate (5ml). Organic layer\nseparated and concentrated to give crude product which was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009); Column Xtimate Prep C18 OBD,21.2x250mm, 10\num; Mobile Phase A: Water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in 8.0\nmin,stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(2-\n(tert-butoxy)ethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-\n</text>\n<text id=p81.i0>\nyl)acetic acid (29 mg, 0.051 mmol, 59.8 % yield) as white solid. LCMS (M+H)=554.2;\nRetention time (10 mM NH4HCO3)=1.631 min.lHNMR(400 MHz,MeOD) δ8.40 (t, J\n=3.3Hz,1H),8.14(d,J=5.0Hz,1H),7.60(dd,J=8.6,2.8Hz,1H),7.47(dd,J=8.6,5.6\nHz,1H),5.81(s,1H),4.31-4.21(m,2H),3.87-3.75(m,2H),3.18-2.58(m,5H),2.14-\n1.10 (m, 32H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 70.Step 1",
                    "iupac_name": "isopropyl (2S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p80.i3"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.101 mmol)in (10\nmL),was added 2-(tert-butoxy)ethyl methanesulfonate (39.6 mg,0.202 mmol) and K2CO3\n(41.8 mg,0.303 mmol). The mixture was stirred for 20 hours at 45°℃,diluted with water\nand ethyl acetate (30 mL),organic layer separated, washed with brine (20 mL), dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ether acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (2S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (51 mg, 0.081 mmol, 80 %\nyield)as brown oil. LCMS (M+H)=596.3; Retention time (10 mM NH4HCO3)=2.786\nmin.",
                    "refs": null
                },
                {
                    "compound_id": "Example 70.Step 2",
                    "iupac_name": "(2S)-2-(tert-butoxy)-2-(5-(2-(tert-butoxy)ethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_80.mol_0",
                    "detail_ids": [
                        "p80.i6",
                        "p81.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(2-(tert-\nbutoxy)ethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate\n(51 mg,0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide\n(10.27 mg, 0.257 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated\nunder vacuo, diluted with HCl(1N,0.5 ml) and ethyl acetate (5ml). Organic layer\nseparated and concentrated to give crude product which was purified by Prep-HPLC\n{Instrument Gilson 281(PHG-009); Column Xtimate Prep C18 OBD,21.2x250mm, 10\num; Mobile Phase A: Water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in 8.0\nmin,stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(2-\n(tert-butoxy)ethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-\nyl)acetic acid (29 mg, 0.051 mmol, 59.8 % yield) as white solid. LCMS (M+H)=554.2;\nRetention time (10 mM NH4HCO3)=1.631 min.lHNMR(400 MHz,MeOD) δ8.40 (t, J\n=3.3Hz,1H),8.14(d,J=5.0Hz,1H),7.60(dd,J=8.6,2.8Hz,1H),7.47(dd,J=8.6,5.6\nHz,1H),5.81(s,1H),4.31-4.21(m,2H),3.87-3.75(m,2H),3.18-2.58(m,5H),2.14-\n1.10 (m, 32H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    },
    {
        "id": "page84.text3",
        "input": [
            {
                "role": "system",
                "content": "\nYou are a chemical synthesis extraction agent. Your job is to extract **each synthesis step** from chemical patent text, with strict adherence to original structure and wording, and no cross-step inference. Follow the rules below carefully.\n\n---\n\n# Background\n\nThe input consists of patent text converted from PDF, marked with explicit region tags:\n- <text id=page###.id##> … </text>: OCR'd paragraph, sentence, or bullet.\n- <mol id=page###.id##> … </mol>: One molecular structure, with an ID.\n- <table id=page###.id###> … </table>: Markdown-format table data.\n- <scheme id=page###.id##> … </scheme>: Synthesis route image as Markdown table.\n\n**Tags are always top-level, never nested, and maintain page order. All IDs must be preserved exactly as in the source.**\n\n---\n\n# Extraction Task\n\nExtract **every synthesis step** as a separate record (never group multiple steps together), regardless of how compounds or examples are organized in the patent.\nFor each step, extract these fields:\n---\n\n## 1. `compound_id`\n- The identifier of the **final product of this synthesis step** (e.g., \"Compound 2\", \"Intermediate B\").\n- For a sub-step product without an explicit identifier but within a section title, construct the compound_id as:  `[Section Title].[Sub-step Label]`  \n  E.g., \"Example 5.Step 2\" (use original wording for both section and sub-step).\n- If the step **explicitly names** the product (e.g., \"to give Compound 4\", \"affording Intermediate B\"), use that exact label.\n- If this is the **final product-forming step** under a section title (like \"Example 5\", \"Compound 3\", \"Preparation 2\") and the product is not otherwise named, assign the section title as the `compound_id`.\n- Only the last step in such a section may receive the section title as `compound_id`.\n- If the step is not within any titled section and lacks a product identifier, set `compound_id` to \"\".\n\n\n## 2. `iupac_name`\n- The IUPAC name of the product synthesized in this step.\n- If it is explicitly stated in the step heading or text, use it.\n- If not, and this is the final product and referred to as \"the title compound,\" you may use the title IUPAC name if it exist.\n- Otherwise, set to \"\".\n- **Never infer, summarize, or fabricate names based on other steps or reagents.**\n\n## 3. `structure_id`\n- Only assign a structure_id if a <mol> tag is present and represents the final product of the entire Example/Section (not for every intermediate or step product).\n- Most steps will have structure_id: \"\".\n- If a structure drawing is given, link its ID only to the last product-forming step in that Example/Section.\n- Never infer or fabricate a structure_id.\n\n\n## 4. `detail_ids`\n- An ordered list of `<text id=...>` blocks containing the synthesis procedure for this step.\n- Include only blocks describing the actual experimental procedure for this step.\n- Do not include analytical data unless mixed with procedural text.\n- Each ID must point to a complete block.\n\n## 5. `detail`\n- Concatenate, in order, the verbatim text of all blocks listed in `detail_ids`.\n- A thorough and continuous text describing the synthesis steps, conditions, observations, and any relevant analytical data (e.g., NMR, LCMS) for the compound.\n- **No paraphrasing or summarization. Only literal extraction.**\n\n## 6. `refs`\n- A list of compound identifiers (e.g., \"Compound 1\", \"Intermediate A\") referenced as precursors, reagents, or intermediates in this step.\n- Only exact, formal identifiers as found in the text.\n- Never include chemical names, structures, or SMILES.\n- If no previous compounds are referenced, set to `null` (do not use an empty list).\n\n---\n\n# Output Format\n\nWrap all steps in a single JSON object as follows:\n\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\", ...],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    },\n    { ... }\n  ]\n}\n```\nField order and structure must be strictly followed.\n\n---\n\n# Extraction Rules\n\n1. One record per synthesis step—even if steps are within a single Example/Compound section.\n\n2. Support all text formats, including:\n  - Compound ID + structure + IUPAC name + procedure\n  - Compound ID + route diagram + multi-step synthesis\n  - Only IUPAC name + procedure\n  - IUPAC name + structure + procedure\n  - Numbered steps within an Example\n  - Long, unsegmented procedural blocks (treat as one step if only one product is described)\n\n3. Never combine steps—always split at clearly marked \"Step\" boundaries or by explicit process transitions.\n\n4. No cross-step inference—never borrow, infer, or synthesize data from other steps or context.\n\n5. Edge Cases:\n  - If no explicit step labels, split based on clear process boundaries (e.g., “Then was added…”).\n  - If only a chemical name is present for the product (no identifier), set compound_id to \"\", use the name.\n  - For refs, only include labels for compounds explicitly referenced as reactants, intermediates, or reagents.\n\n6. Indirect Naming:\n - Accept references like \"the title compound\", \"the desired product\", \"the compound obtained in Step 2\" as meaning the current product but do NOT use them as compound_id or iupac_name.\n - Use section titles as compound_id only when rules above apply.\n\n7. Multiple Steps under One Example:\n - Each step must be separate.\n - Only the final step in the section can take the section title as compound_id.\n - Intermediate steps: assign compound_id as per the above rules.\n"
            },
            {
                "role": "user",
                "content": "<text id=p84.i1>\nExample 75\n</text>\n<mol id=p84.i2>\npage_84.mol_0\n</mol>\n<text id=p84.i3>\n(2S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydro-2H-\npyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and (tetrahydro-2H-pyran-4-yl)methyl\nmethanesulfonate (29.4 mg,0.151mmol).The mixture was stirred for 20 hours at 45°C,\ndiluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate (53 mg,0.085 mmol,\n84% yield) as yellow oil. LCMS (M +H)=594.2; Retention time (10 mM NH4HCO3)=\n2.565 min.\n</text>\n<text id=p84.i7>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-\n5'-yl)acetate (53 mg, 0.089 mmol) in methanol (10 mL) and water(2 mL) was added\nNaOH(10.71 mg, 0.268 mmol) and stirred for 20 hours at 100 °C.The mixture was\nconcentrated under vacuo, diluted with HCl(1N,0.5 ml) and ethyl acetate (5ml). Organic\nlayer separated and concentrated to give crude product which was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10\num; Mobile Phase A: Water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in 8.0\n</text>\n<text id=p85.i0>\nmin,stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-\nbipyridin]-5'-yl)acetic acid (3.9 mg, 6.84 umol, 7.66 % yield) as white solid. LCMS (M +\nH)= 552.2; Retention time (10 mM NH4HCO3)= 1.522 min.lHNMR (400 MHz, MeOD)\n88.40-8.34(m,1H),8.13(d,J=9.5Hz,1H),7.62-7.53(m,1H),7.50-7.42(m,1H),\n5.96(s, 1H),4.09-3.97(m,4H),3.51(t,J=11.7Hz,2H),3.18-2.58(m,5H), 2.23-1.26\n(m,19H),1.20(s,9H).\n</text>\n"
            }
        ],
        "output": {
            "results": [
                {
                    "compound_id": "Example 75.Step 1",
                    "iupac_name": "isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate",
                    "structure_id": "",
                    "detail_ids": [
                        "p84.i3"
                    ],
                    "detail": "Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and (tetrahydro-2H-pyran-4-yl)methyl\nmethanesulfonate (29.4 mg,0.151mmol).The mixture was stirred for 20 hours at 45°C,\ndiluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetate (53 mg,0.085 mmol,\n84% yield) as yellow oil. LCMS (M +H)=594.2; Retention time (10 mM NH4HCO3)=\n2.565 min.",
                    "refs": null
                },
                {
                    "compound_id": "Example 75.Step 2",
                    "iupac_name": "(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-5'-yl)acetic acid",
                    "structure_id": "page_84.mol_0",
                    "detail_ids": [
                        "p84.i7",
                        "p85.i0"
                    ],
                    "detail": "Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-bipyridin]-\n5'-yl)acetate (53 mg, 0.089 mmol) in methanol (10 mL) and water(2 mL) was added\nNaOH(10.71 mg, 0.268 mmol) and stirred for 20 hours at 100 °C.The mixture was\nconcentrated under vacuo, diluted with HCl(1N,0.5 ml) and ethyl acetate (5ml). Organic\nlayer separated and concentrated to give crude product which was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10\num; Mobile Phase A: Water (10 mM NH4HCO3);B: MeCN; Gradient 40-68%B in 8.0\nmin,stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-((tetrahydro-2H-pyran-4-yl)methoxy)-[2,3'-\nbipyridin]-5'-yl)acetic acid (3.9 mg, 6.84 umol, 7.66 % yield) as white solid. LCMS (M +\nH)= 552.2; Retention time (10 mM NH4HCO3)= 1.522 min.lHNMR (400 MHz, MeOD)\n88.40-8.34(m,1H),8.13(d,J=9.5Hz,1H),7.62-7.53(m,1H),7.50-7.42(m,1H),\n5.96(s, 1H),4.09-3.97(m,4H),3.51(t,J=11.7Hz,2H),3.18-2.58(m,5H), 2.23-1.26\n(m,19H),1.20(s,9H).",
                    "refs": null
                }
            ]
        },
        "model": "GPT",
        "status": "DONE",
        "name": "reaction_desc",
        "header_name": ""
    }
]